NCT04678648
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
At risk: Primary completion moved at least 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 15 versions: 11 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 15 words
- Primary completion pushed from Dec 15, 2026 to Mar 16, 2027
- Study completion pushed from Jan 30, 2027 to Mar 17, 2028
- Site details revised at 1 of 3 sites
- Notable Eligibility criteria expanded, about 33 words
- Secondary endpoints: 2 to 3
- Study description expanded, about 11 words
- Study sites revised (3)
- Notable Primary completion date: Jul 2, 2025 to Dec 15, 2026
- Study sites: 5 to 3
- Study completion date: Sep 1, 2025 to Jan 30, 2027
- Start date: Feb 16, 2021 to Mar 3, 2021
- Notable Primary completion date: Jan 16, 2024 to Jul 2, 2025
- Study sites: 6 to 5
- Study completion date: Mar 5, 2024 to Sep 1, 2025
- Minor Site details revised at 1 of 6 sitesv7
Show 5 earlier versionsHide 5 earlier versions
- Minor Site details revised at 1 of 6 sitesv6
- Minor Site details revised at 1 of 6 sitesv5
- Minor Site details revised at 1 of 6 sitesv4
- Minor Site details revised at 1 of 6 sitesv3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 1 to 6
- Start date changed from estimate of Jan 15, 2021 to Feb 16, 2021
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Maximum Tolerated Dose (MTD) for RSC-1255 as monotherapy
Timeframe: Approximately 30 months
Recommended Phase 2 Dose (RP2D) for RSC-1255 as monotherapy
Timeframe: Approximately 12 months
Secondary (3)
Adverse event profile of RSC-1255
Overall Survival (OS)
Disease Progression
Arms and interventions
RSC-1255 TreatmentExperimental
Single Arm Study. All study participants receive RSC-1255.
Drugs: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion
Sites
3 sites in 1 country